Opaleye Management Inc. Reata Pharmaceuticals Inc Transaction History

Opaleye Management Inc.

  • $548 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$20.71 - $36.5 $4.62 Million - $8.15 Million
-223,252 Reduced 54.85%
183,750 $5.58 Million
Q1 2022

May 16, 2022
BUY
$24.12 - $39.6 $1.86 Million - $3.05 Million
77,002 Added 23.33%
407,002 $13.3 Million
Q4 2021

Feb 14, 2022
BUY
$25.61 - $110.96 $8.45 Million - $36.6 Million
330,000 New
330,000 $8.7 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email